Facebook Linkedin RSS Twitter Youtube
Home 2024

Chronic lymphocytic leukemia

p53 Variant Gives CAR T Cell Therapy a Boost
Cancer

p53 Variant Gives CAR T Cell Therapy a Boost

Checkpoint Molecule Could Be New Cancer Immunotherapy Target
Cancer

Checkpoint Molecule Could Be New Cancer Immunotherapy Target

CEPI Gives Novavax Up to $384M for COVID-19 Vaccine R&D, Manufacturing
Coronavirus

CEPI Gives Novavax Up to $384M for COVID-19 Vaccine R&D, Manufacturing

Using Nanopore Sequencing to Study Full-Length Transcripts and Splicing Isoforms
Cancer

Using Nanopore Sequencing to Study Full-Length Transcripts and Splicing Isoforms

CLL Drug Study Finds Single-Cell Analysis Can Gauge Patients’ Response Rates
Cancer

CLL Drug Study Finds Single-Cell Analysis Can Gauge Patients’ Response Rates

Mission Bio Raises $30M, Plans for Expansion into Gene Editing, Further Tapestri Platform Development
Featured

Mission Bio Raises $30M, Plans for Expansion into Gene Editing, Further Tapestri Platform Development

Soluble Antibodies Promote Tumor Progression by Inducing Immune Suppressive Cells
Cancer

Soluble Antibodies Promote Tumor Progression by Inducing Immune Suppressive Cells

MorphoSys to Advance Pipeline, Platform Through Up-to-$150M U.S. IPO
Cancer

MorphoSys to Advance Pipeline, Platform Through Up-to-$150M U.S. IPO

AbbVie’s Veliparib Fails in Two Phase III Cancer Combination Therapy Studies
Cancer

AbbVie’s Veliparib Fails in Two Phase III Cancer Combination Therapy Studies

Top 10 M&A Deals of 2016
A-Lists

Top 10 M&A Deals of 2016

123...8Page 1 of 8
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.